Travere Therapeutics, Inc. (TVTX)
USD 14.51
(-3.2%)
USD 14.51
(-3.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 133.78 Million USD | -56.53% |
| 2022 | 204.42 Million USD | -7.38% |
| 2021 | 220.7 Million USD | 14.83% |
| 2020 | 192.19 Million USD | 12.99% |
| 2019 | 170.1 Million USD | 7.17% |
| 2018 | 158.71 Million USD | 4.88% |
| 2017 | 151.33 Million USD | 17.28% |
| 2016 | 129.03 Million USD | 32.07% |
| 2015 | 97.7 Million USD | 253.6% |
| 2014 | 27.63 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 39.87 Million USD | 39.2% |
| 2024 Q3 | 50.03 Million USD | 46.9% |
| 2024 Q2 | 41.71 Million USD | 4.61% |
| 2023 Q4 | 28.64 Million USD | -20.01% |
| 2023 Q2 | 57.7 Million USD | 11.26% |
| 2023 Q3 | 35.8 Million USD | -37.95% |
| 2023 FY | 88.85 Million USD | -56.53% |
| 2023 Q1 | 51.86 Million USD | -4.2% |
| 2022 Q3 | 51.82 Million USD | -0.57% |
| 2022 Q4 | 54.14 Million USD | 4.48% |
| 2022 FY | 204.42 Million USD | -7.38% |
| 2022 Q2 | 52.11 Million USD | 12.44% |
| 2022 Q1 | 46.34 Million USD | -16.27% |
| 2021 FY | 220.7 Million USD | 14.83% |
| 2021 Q4 | 55.35 Million USD | -16.92% |
| 2021 Q1 | 45.76 Million USD | -6.44% |
| 2021 Q2 | 52.96 Million USD | 15.74% |
| 2021 Q3 | 66.62 Million USD | 25.79% |
| 2020 Q4 | 48.91 Million USD | -2.08% |
| 2020 Q3 | 49.95 Million USD | 6.42% |
| 2020 Q1 | 46.39 Million USD | 3.2% |
| 2020 Q2 | 46.93 Million USD | 1.16% |
| 2020 FY | 192.19 Million USD | 12.99% |
| 2019 Q3 | 42.86 Million USD | -1.98% |
| 2019 FY | 170.1 Million USD | 7.17% |
| 2019 Q1 | 38.55 Million USD | -8.57% |
| 2019 Q2 | 43.72 Million USD | 13.42% |
| 2019 Q4 | 44.96 Million USD | 4.9% |
| 2018 Q1 | 36.81 Million USD | -10.2% |
| 2018 FY | 158.71 Million USD | 4.88% |
| 2018 Q4 | 42.16 Million USD | 6.56% |
| 2018 Q3 | 39.57 Million USD | -1.46% |
| 2018 Q2 | 40.15 Million USD | 9.07% |
| 2017 Q3 | 39.41 Million USD | 3.72% |
| 2017 Q1 | 32.91 Million USD | -8.89% |
| 2017 FY | 151.33 Million USD | 17.28% |
| 2017 Q4 | 41 Million USD | 4.03% |
| 2017 Q2 | 38 Million USD | 15.47% |
| 2016 Q1 | 28.25 Million USD | -4.83% |
| 2016 Q3 | 32.37 Million USD | 0.25% |
| 2016 FY | 129.03 Million USD | 32.07% |
| 2016 Q4 | 36.12 Million USD | 11.59% |
| 2016 Q2 | 32.29 Million USD | 14.3% |
| 2015 FY | 97.7 Million USD | 253.6% |
| 2015 Q4 | 29.68 Million USD | 7.98% |
| 2015 Q1 | 17.09 Million USD | 24.37% |
| 2015 Q3 | 27.49 Million USD | 17.33% |
| 2015 Q2 | 23.43 Million USD | 37.04% |
| 2014 Q4 | 13.74 Million USD | 68.65% |
| 2014 FY | 27.63 Million USD | 0.0% |
| 2014 Q1 | 27 Thousand USD | -73.0% |
| 2014 Q2 | 4.53 Million USD | 16693.85% |
| 2014 Q3 | 8.15 Million USD | 79.77% |
| 2013 Q4 | 100 Thousand USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -251.842% |
| Alkermes plc | 1.37 Billion USD | 90.268% |
| Agenus Inc. | 139.61 Million USD | 4.174% |
| Aptorum Group Limited | -1.11 Million USD | 12102.282% |
| Ardelyx, Inc. | 106.66 Million USD | -25.433% |
| Dyadic International, Inc. | 922.95 Thousand USD | -14395.583% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -535.24% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 76618.934% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1101.569% |
| Novavax, Inc. | 639.93 Million USD | 79.094% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 385.634% |
| Pyxis Oncology, Inc. | -2 Million USD | 6789.4% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 25990.476% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -602.557% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 302869.983% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 25486.717% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 236.217% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -16581.796% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 163256.098% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 1.095% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1599.759% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 237.997% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 91.186% |
| AlloVir, Inc. | -398 Thousand USD | 33715.075% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 44.425% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -31453.774% |
| Bicycle Therapeutics plc | -129.52 Million USD | 203.295% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -111390.0% |
| ChromaDex Corporation | 50.78 Million USD | -163.466% |
| Chimerix, Inc. | 324 Thousand USD | -41192.593% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 529.253% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 272.412% |
| CRISPR Therapeutics AG | 240.95 Million USD | 44.476% |
| Precision BioSciences, Inc. | 40.47 Million USD | -230.569% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 236.292% |
| Fortress Biotech, Inc. | 57.85 Million USD | -131.255% |
| Fortress Biotech, Inc. | 57.85 Million USD | -131.255% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -707.07% |
| ImmuCell Corporation | 4.39 Million USD | -2943.206% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 226.069% |
| Immix Biopharma, Inc. | -5468.00 USD | 2446844.696% |
| Incyte Corporation | 3.44 Billion USD | 96.112% |
| Innoviva, Inc. | 261.06 Million USD | 48.753% |
| IO Biotech, Inc. | -756 Thousand USD | 17796.825% |
| Jaguar Health, Inc. | 7.72 Million USD | -1632.108% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 20248.795% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -11.72% |
| ContextLogic Inc. | 59 Million USD | -126.759% |
| MiMedx Group, Inc. | 266.84 Million USD | 49.863% |
| MEI Pharma, Inc. | 49.32 Million USD | -171.227% |
| NextCure, Inc. | -3.68 Million USD | 3731.596% |
| Onconetix, Inc. | -1.12 Million USD | 11969.425% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 561.848% |
| Opthea Limited | 21.72 Thousand USD | -615866.851% |
| Psyence Biomedical Ltd. | -240.00 USD | 55745100.0% |
| Vaxcyte, Inc. | -75 Million USD | 278.384% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 233481.014% |
| Precigen, Inc. | 106 Thousand USD | -126115.094% |
| Pharming Group N.V. | 220.1 Million USD | 39.216% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -25878.252% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -13159.465% |
| PureTech Health plc | -1.6 Million USD | 8446.101% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -21.878% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 173.75% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 395.175% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 708.487% |
| Acelyrin, Inc. | -115 Thousand USD | 116437.391% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1331191.434% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6626.244% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 23530.473% |
| Senti Biosciences, Inc. | -2.68 Million USD | 5086.508% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3202.592% |
| Elevation Oncology, Inc. | -39 Thousand USD | 343146.154% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2888.412% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3493.87% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -359.295% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -26873.387% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 243350.909% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -28.52% |
| Seer, Inc. | 7.02 Million USD | -1803.913% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2955.916% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -520.97% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 113009.841% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 93461.526% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -21868.473% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -11.051% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 57.348% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2675860.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -5097.669% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 263773.63% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -355.263% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 57767.241% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 27292.683% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1984.869% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 28292.901% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1286523.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -137384.971% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1337.746% |
| Kura Oncology, Inc. | -849 Thousand USD | 15858.304% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 299.374% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 91112.245% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -35.086% |
| Autolus Therapeutics plc | -4.86 Million USD | 2848.88% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -223.269% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 79735.714% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -41.241% |
| GRI Bio, Inc. | 10.84 Million USD | -1134.093% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -5167.273% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1640.094% |
| IGM Biosciences, Inc. | -211.66 Million USD | 163.209% |
| INmune Bio, Inc. | 155 Thousand USD | -86214.839% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -116.0% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8981.949% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 20731.841% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 457119.881% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -33180.597% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 6802.806% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 42843.77% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -41.633% |
| Verastem, Inc. | -62 Thousand USD | 215887.097% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5394.374% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 51359.77% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4319.822% |
| Histogen Inc. | 3.76 Million USD | -3449.695% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -23119.867% |
| Surrozen, Inc. | -27.23 Million USD | 591.326% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2582.613% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 11203.844% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 621.652% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -567.205% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 6757069.697% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2105.385% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 199393.918% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 13.569% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -91661.317% |
| Apollomics, Inc. | 127 Thousand USD | -105244.882% |
| Amarin Corporation plc | 165.54 Million USD | 19.181% |
| Mesoblast Limited | -9.81 Million USD | 1463.097% |
| Turnstone Biologics Corp. | 16.5 Million USD | -710.542% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 221.087% |
| Synaptogenix, Inc. | -6347.00 USD | 2107993.493% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 262429.412% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 17.09% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 92.388% |
| Better Therapeutics, Inc. | -2.72 Million USD | 5002.455% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 219.282% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 60.427% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1172855.961% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2237.188% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12174.729% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1728.204% |
| Insmed Incorporated | 239.63 Million USD | 44.17% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3639.184% |
| OmniAb, Inc. | 14.66 Million USD | -812.17% |
| Alector, Inc. | -95.05 Million USD | 240.751% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -6.501% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 407.82% |
| Zai Lab Limited | 170.9 Million USD | 21.717% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -63.401% |
| Aura Biosciences, Inc. | -1.29 Million USD | 10431.12% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -102813.846% |
| Immunic, Inc. | -111 Thousand USD | 120629.73% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -743.875% |
| Veracyte, Inc. | 248.14 Million USD | 46.085% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.914% |
| FibroGen, Inc. | 128.9 Million USD | -3.789% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 23721376.596% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1246.733% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.063% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -34292.802% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 62.35% |
| TG Therapeutics, Inc. | 219.1 Million USD | 38.94% |
| Galecto, Inc. | -830 Thousand USD | 16219.036% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 9759.783% |
| Fortrea Holdings Inc. | 424 Million USD | 68.446% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 255.266% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 23695.767% |
| XBiotech Inc. | -1.74 Million USD | 7771.33% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12174.729% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 387.896% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 277.123% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -82.265% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -696.215% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 65.611% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 369.479% |
| Vaxxinity, Inc. | -2.23 Million USD | 6088.72% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 59.055% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1281.472% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -447.168% |
| NexImmune, Inc. | -1.02 Million USD | 13152.844% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2477455.556% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1982.838% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.816% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 200300.518% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3867.615% |
| Ainos, Inc. | -253.73 Thousand USD | 52827.867% |
| Pluri Inc. | 322 Thousand USD | -41449.068% |
| Prothena Corporation plc | -129.2 Million USD | 203.55% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -165.326% |
| Celularity Inc. | 6.75 Million USD | -1880.577% |
| Rallybio Corporation | -150 Thousand USD | 89292.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 510.305% |
| MeiraGTx Holdings plc | 287 Thousand USD | -46516.028% |
| Omeros Corporation | -69.77 Million USD | 291.731% |
| Humacyte, Inc. | -76.55 Million USD | 274.772% |
| Immunocore Holdings plc | 248.39 Million USD | 46.138% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 981.983% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -114.466% |
| Blueprint Medicines Corporation | 236.58 Million USD | 43.45% |
| CalciMedica, Inc. | -58 Thousand USD | 230768.966% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 9482.048% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -360.465% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 4804.219% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 533.462% |
| Pulmatrix, Inc. | -8.22 Million USD | 1727.591% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 11534.872% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 33630.827% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 133.548% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4720.173% |
| Cytokinetics, Incorporated | -322.59 Million USD | 141.473% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -15418.759% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 39334.018% |
| Vor Biopharma Inc. | -3.49 Million USD | 3931.271% |
| Roivant Sciences Ltd. | 109.23 Million USD | -22.477% |
| Evogene Ltd. | 1.39 Million USD | -9463.117% |
| ProKidney Corp. | -3.16 Million USD | 4321.773% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 404.673% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1851.116% |
| CorMedix Inc. | -205.56 Thousand USD | 65184.014% |
| BioLineRx Ltd. | 1.1 Million USD | -11974.729% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 270.06% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 405518.182% |
| Atai Life Sciences N.V. | -5000.00 USD | 2675860.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 109889.183% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 139462.5% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 9731.965% |
| Sagimet Biosciences Inc. | 2 Million USD | -6589.4% |
| MediciNova, Inc. | 979.7 Thousand USD | -13555.947% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 258.669% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 141592.253% |
| GeoVax Labs, Inc. | -20.72 Million USD | 745.671% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 45.289% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3284.67% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 84.663% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1701.616% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 43257.419% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1115000.0% |
| Absci Corporation | -41.84 Million USD | 419.692% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2675860.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 275.177% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5536.327% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 37.405% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 14317.641% |
| Allakos Inc. | -6.14 Million USD | 2278.603% |
| Imunon, Inc. | -720 Thousand USD | 18681.538% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 293.907% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 71.887% |
| BioAtla, Inc. | -103.73 Million USD | 228.976% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1172855.961% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 75261.798% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 155.098% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 43118.65% |
| XOMA Corporation | 3.86 Million USD | -3365.113% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 290.894% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -804.34% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5702.513% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -973.74% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 461437.931% |
| Viridian Therapeutics, Inc. | -1 Million USD | 13372.619% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1029138361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 3344800.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 78.994% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -68612.123% |
| UroGen Pharma Ltd. | 73.35 Million USD | -82.392% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 601.191% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1152251.421% |
| Orgenesis Inc. | -5.72 Million USD | 2436.908% |
| Entera Bio Ltd. | -56 Thousand USD | 239007.143% |
| GH Research PLC | -315 Thousand USD | 42572.381% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 70887.302% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 25583.429% |
| Xencor, Inc. | -85.26 Million USD | 256.918% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 60643.858% |
| Replimune Group, Inc. | -2.65 Million USD | 5139.096% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 13462.284% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 24.772% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -68612.123% |
| Portage Biotech Inc. | -54 Thousand USD | 247855.556% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 141592.253% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 35587.533% |
| OncoCyte Corporation | 413 Thousand USD | -32294.189% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2976473.749% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 60264964.865% |
| Purple Biotech Ltd. | -196 Thousand USD | 68359.184% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1391.838% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1267.696% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1380.886% |
| HilleVax, Inc. | -2.15 Million USD | 6305.38% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 138025.773% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 891782.218% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 20128.144% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 581786.957% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1782476.075% |
| Savara Inc. | -44.26 Million USD | 402.264% |
| Curis, Inc. | 9.81 Million USD | -1263.653% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4730.725% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 107312.232% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 7837.883% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 58778.947% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.564% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 4885.15% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 133.475% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -136.008% |
| Erasca, Inc. | -3.73 Million USD | 3684.887% |
| bluebird bio, Inc. | -4.03 Million USD | 3419.801% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 474222.9% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 92.975% |
| DBV Technologies S.A. | 15.72 Million USD | -750.636% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 474222.9% |
| Moderna, Inc. | 2.15 Billion USD | 93.792% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 14721.639% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1571.097% |
| Molecular Templates, Inc. | 50.39 Million USD | -165.479% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 25060.448% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2250.241% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 440.055% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 220.391% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3828.763% |
| MacroGenics, Inc. | 50.52 Million USD | -164.785% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2293.965% |
| Prime Medicine, Inc. | -147.9 Million USD | 190.455% |
| Aditxt, Inc. | -111.66 Thousand USD | 119917.303% |
| Adagene Inc. | 18.11 Million USD | -638.691% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -27315.574% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 4.575% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 15.236% |
| SciSparc Ltd. | 2.19 Million USD | -5992.35% |
| Vericel Corporation | 135.57 Million USD | 1.319% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 534205.154% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 431924.931% |
| Generation Bio Co. | -73.91 Million USD | 281.012% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 30715.103% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -144.948% |
| Invivyd, Inc. | -2.02 Million USD | 6697.041% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 144.471% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 129441.248% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -38.83% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -36.118% |
| ADMA Biologics, Inc. | 88.21 Million USD | -51.656% |
| Clene Inc. | 533 Thousand USD | -25000.938% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -454.925% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 14079.937% |
| GeoVax Labs, Inc. | -20.72 Million USD | 745.671% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6629.779% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 68950.738% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -168.624% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1986.464% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 16103.349% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -60.388% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -182890.48% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -151.661% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 177.25% |
| Trevena, Inc. | 1.45 Million USD | -9095.052% |
| Surrozen, Inc. | -27.23 Million USD | 591.326% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 38000.283% |
| Cingulate Inc. | -582.91 Thousand USD | 23051.427% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 431674.194% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 779.161% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1767444.782% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 15285.925% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 80.346% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 13641.296% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 237556.959% |
| Kronos Bio, Inc. | 1.37 Million USD | -9651.312% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 349.298% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 45917.808% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 27497.945% |
| ImmunityBio, Inc. | -17.89 Million USD | 847.837% |
| Korro Bio, Inc. | -3.63 Million USD | 3785.62% |
| Kineta, Inc. | 5.43 Million USD | -2362.507% |
| BioVie Inc. | -229.37 Thousand USD | 58426.685% |
| Codexis, Inc. | 57.33 Million USD | -133.348% |
| Celularity Inc. | 6.75 Million USD | -1880.577% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3233.865% |
| Celcuity Inc. | -142.77 Thousand USD | 93807.45% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -264355.426% |
| Cibus, Inc. | 1.42 Million USD | -9308.439% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 35872.193% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 683.743% |
| IN8bio, Inc. | -2.5 Million USD | 5449.38% |
| Kodiak Sciences Inc. | -25.94 Million USD | 615.62% |
| Annexon, Inc. | -3.26 Million USD | 4195.133% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 6645.401% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 420.55% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -20804.375% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 82.815% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 22.646% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 7141.474% |
| Arcellx, Inc. | 108.27 Million USD | -23.559% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 513.321% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -68.916% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 732.508% |
| Moolec Science SA | -143.3 Thousand USD | 93458.92% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 416.149% |
| Geron Corporation | -123.5 Million USD | 208.328% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3970.216% |
| Royalty Pharma plc | 1.79 Billion USD | 92.542% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 290.88% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3704086.711% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -57719.016% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 220.082% |
| Humacyte, Inc. | -76.55 Million USD | 274.772% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 14195.203% |
| 89bio, Inc. | -273 Thousand USD | 49106.593% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 10743.437% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 15876.887% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 108870.732% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -11856.032% |
| Notable Labs, Ltd. | 113 Thousand USD | -118296.46% |
| Liquidia Corporation | 14.6 Million USD | -816.356% |
| Mustang Bio, Inc. | -2.22 Million USD | 6112.944% |
| Immunovant, Inc. | -231 Thousand USD | 58016.883% |
| Quantum-Si incorporated | 488 Thousand USD | -27315.574% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 340.803% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 446060.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -7085.177% |
| Acasti Pharma Inc. | -11 Thousand USD | 1216354.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 65484.597% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 20731.841% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 179.868% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -11691.852% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 35214.961% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 6932.891% |
| PepGen Inc. | -1.18 Million USD | 11399.662% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 105444.882% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.537% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 684.304% |
| Solid Biosciences Inc. | -76.56 Million USD | 274.742% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 162104.287% |
| Immuneering Corporation | -764.13 Thousand USD | 17608.356% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -201801.485% |
| Belite Bio, Inc | -399 Thousand USD | 33630.827% |
| XOMA Corporation | 3.86 Million USD | -3365.113% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 767.738% |
| Bionomics Limited | -434.44 Thousand USD | 30894.869% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 12556.983% |
| uniQure N.V. | 2.21 Million USD | -5940.09% |
| Cassava Sciences, Inc. | -89.42 Million USD | 249.613% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 245.313% |
| Forte Biosciences, Inc. | -9000.00 USD | 1486633.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 16122.515% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 30715.103% |
| Altimmune, Inc. | -65.37 Million USD | 304.653% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 63.045% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 12556.983% |
| Compugen Ltd. | 31.45 Million USD | -325.331% |
| Peak Bio, Inc. | 367.76 Thousand USD | -36278.27% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -445.717% |
| Benitec Biopharma Inc. | 108 Thousand USD | -123777.778% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 171623.077% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 11221.197% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 7442.92% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 112526.891% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 11221.197% |
| Instil Bio, Inc. | -4.75 Million USD | 2913.036% |
| argenx SE | 1.1 Billion USD | 87.931% |
| Immunome, Inc. | -8.9 Million USD | 1602.055% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 7178.73% |
| Verona Pharma plc | -679.62 Thousand USD | 19785.591% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 76550.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5709.56% |
| CervoMed Inc. | -1.29 Million USD | 10442.085% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5658.288% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2900.67% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -5314.326% |
| Moolec Science SA | -143.3 Thousand USD | 93458.92% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 32888.766% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 5107.921% |
| AnaptysBio, Inc. | 14.78 Million USD | -805.135% |
| Design Therapeutics, Inc. | -537 Thousand USD | 25013.966% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 31432.084% |
| NeurAxis, Inc. | 2.15 Million USD | -6103.355% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -6134.296% |
| Lumos Pharma, Inc. | 2 Million USD | -6566.069% |
| Achilles Therapeutics plc | -4.73 Million USD | 2927.741% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 76550.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 126703.265% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -322.594% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -15418.759% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 13063.953% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 393.73% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -311034.884% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 16375.912% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1016880.666% |
| Palisade Bio, Inc. | 246 Thousand USD | -54285.366% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 405518.182% |
| Beam Therapeutics Inc. | -59.67 Million USD | 324.206% |
| Neurogene Inc. | -3.26 Million USD | 4201.41% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 3.981% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3723.727% |
| Sesen Bio, Inc. | 40 Million USD | -234.47% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 45146.465% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3422.244% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1498.578% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -850.199% |
| Athira Pharma, Inc. | -969 Thousand USD | 13906.811% |
| Vaccinex, Inc. | -16 Million USD | 935.966% |
| HCW Biologics Inc. | -574.82 Thousand USD | 23374.602% |
| XOMA Corporation | 3.86 Million USD | -3365.113% |
| Nektar Therapeutics | 53.47 Million USD | -150.174% |
| Arvinas, Inc. | 71.8 Million USD | -86.334% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 260.3% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 313.123% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 41649.068% |
| Rezolute, Inc. | -36 Thousand USD | 371733.333% |
| Clene Inc. | 533 Thousand USD | -25000.938% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 10419726.168% |
| BeyondSpring Inc. | 1.75 Million USD | -7540.662% |
| Synlogic, Inc. | -1.92 Million USD | 7053.638% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 361689.189% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2212.887% |
| Peak Bio, Inc. | 367.76 Thousand USD | -36278.27% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 805.521% |
| Krystal Biotech, Inc. | 47.6 Million USD | -181.038% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 5.176% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2562.448% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 5267.118% |
| MannKind Corporation | 136.19 Million USD | 1.764% |
| Ikena Oncology, Inc. | -50.49 Million USD | 364.969% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -22.951% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3151.038% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 53190.476% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2675860.0% |
| Legend Biotech Corporation | 140.92 Million USD | 5.067% |
| Mural Oncology plc | -2.56 Million USD | 5311.843% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 24380.944% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 133888.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -544.637% |
| REGENXBIO Inc. | 53.02 Million USD | -152.292% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2597.465% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 69645.419% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 7824.48% |
| Vaxart, Inc. | -60.76 Million USD | 320.18% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 51012.55% |
| Cellectis S.A. | 18 Thousand USD | -743166.667% |
| Longeveron Inc. | 221 Thousand USD | -60437.557% |
| Repare Therapeutics Inc. | -80.07 Million USD | 267.089% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 87.759% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 10439.104% |
| Revolution Medicines, Inc. | -399.66 Million USD | 133.475% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 382351.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -272936.735% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.446% |
| Denali Therapeutics Inc. | -93.34 Million USD | 243.326% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 534205.154% |
| Veru Inc. | 7.56 Million USD | -1668.296% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 88701.325% |
| Cingulate Inc. | -582.91 Thousand USD | 23051.427% |
| Passage Bio, Inc. | -3.72 Million USD | 3695.485% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1110926.968% |
| Exicure, Inc. | -1.42 Million USD | 9501.827% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 35031.593% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -4849.612% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 26196.065% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -96.383% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 89526.297% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 325.97% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -34116.88% |
| OmniAb, Inc. | 14.66 Million USD | -812.17% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -569.174% |
| Lipocine Inc. | -2.85 Million USD | 4792.969% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 7359.251% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2445.101% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 8981.949% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -77.636% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 205927.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -58.712% |
| Ocugen, Inc. | -33.53 Million USD | 498.927% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4331.12% |
| Q32 Bio Inc. | 578 Thousand USD | -23046.713% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 50586.038% |
| Alumis Inc. Common Stock | -1.28 Million USD | 10519.626% |
| Equillium, Inc. | 35.95 Million USD | -272.067% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 7937.61% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -26621.312% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3236384.47% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 51755.598% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -31549.918% |
| Dominari Holdings Inc. | 2.03 Million USD | -6461.452% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 73020.516% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1084.097% |
| Bio-Techne Corporation | 773.07 Million USD | 82.694% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -672.493% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 70.965% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 11544.654% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 657.915% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1043.78% |
| Nkarta, Inc. | -5.86 Million USD | 2379.571% |
| BioCardia, Inc. | -7.24 Million USD | 1945.606% |
| Iterum Therapeutics plc | -1.75 Million USD | 7745.029% |